Sutro Biopharma (STRO) Prepaid Assets (2017 - 2025)
Sutro Biopharma's (STRO) quarterly Prepaid Assets came in at $5.5 million in Q4 2025, down 68.98% year-on-year from $17.8 million in Q4 2024, and down 47.9% quarter-over-quarter from $10.6 million in Q3 2025.
Sutro Biopharma (STRO) Prepaid Assets (2017 - 2025) Analysis & Trends
Sutro Biopharma has disclosed Prepaid Assets across 9 years of filings, most recently posting $5.5 million for Q4 2025.
- Prepaid Assets for Q4 2025 came in at $5.5 million, down 68.98% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.5 million (down 68.98% YoY), and the FY2025 annual result was $5.5 million, down 68.98% from the prior year.
- Prepaid Assets came in at $5.5 million for Q4 2025 at Sutro Biopharma, down from $10.6 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $24.9 million in Q1 2025 to a low of $5.5 million in Q4 2025.
- The 5-year median for Prepaid Assets is $10.2 million (2023), against an average of $11.5 million.
- Across the five-year window, Prepaid Assets jumped 232.69% in 2021 and tumbled 68.98% in 2025, its largest moves.
- Sutro Biopharma's Prepaid Assets stood at $8.1 million in 2021, then jumped by 43.63% to $11.7 million in 2022, then retreated by 15.61% to $9.8 million in 2023, then soared by 80.77% to $17.8 million in 2024, then tumbled by 68.98% to $5.5 million in 2025.
- The last three Prepaid Assets figures came in at $5.5 million (Q4 2025), $10.6 million (Q3 2025), and $18.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Sutro Biopharma | 252.04 Mn | 252.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.52 Mn |
| Sep 30, 2025 | 10.60 Mn |
| Jun 30, 2025 | 18.50 Mn |
| Mar 31, 2025 | 24.88 Mn |
| Dec 31, 2024 | 17.80 Mn |
| Sep 30, 2024 | 10.87 Mn |
| Jun 30, 2024 | 10.53 Mn |
| Mar 31, 2024 | 10.06 Mn |
| Dec 31, 2023 | 9.85 Mn |
| Sep 30, 2023 | 9.48 Mn |
| Jun 30, 2023 | 10.34 Mn |
| Mar 31, 2023 | 17.70 Mn |
| Dec 31, 2022 | 11.67 Mn |
| Sep 30, 2022 | 11.06 Mn |
| Jun 30, 2022 | 8.20 Mn |
| Mar 31, 2022 | 7.91 Mn |
| Dec 31, 2021 | 8.12 Mn |
| Sep 30, 2021 | 8.70 Mn |
| Jun 30, 2021 | 9.75 Mn |
| Mar 31, 2021 | 7.55 Mn |